RD

Reshmi Deevathum Kavil

Active Director Designated Partner DIN 09653990
DIN 09653990 First appointment Jul 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Reshmi Deevathum Kavil

Data last updated:

Reshmi Deevathum Kavil is a Designated Partner at Sevacare Polyclinic & Diagnostic Center Llp (since 2022). The company operates in Healthcare.

DIN 09653990
Primary Designation Designated Partner
Industry Healthcare
First Appointment 30 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 Jul 20222022Active

Board colleagues of Reshmi Deevathum Kavil

Directorship timeline

Open interactive timeline →
Sevacare Polyclinic & Diagnostic Center Llp
Premium access

Shareholding and investment profile for Reshmi Deevathum Kavil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reshmi Deevathum Kavil

Reshmi Deevathum Kavil currently holds 1 directorship: Sevacare Polyclinic & Diagnostic Center Llp (Designated Partner, since 30 Jul 2022).

Reshmi Deevathum Kavil was first appointed on 30 Jul 2022 as Designated Partner at Sevacare Polyclinic & Diagnostic Center Llp.

The current boards of Reshmi Deevathum Kavil's companies include Chathanur Suresh (Sevacare Polyclinic & Diagnostic Center Llp), Greeshma G Nair (Sevacare Polyclinic & Diagnostic Center Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available